STF-logo-1

We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Skyscrapers-manhattan_GettyImages-1189547724-Edited

The 

power

of our 

people

and 

platform

Focus

Excellence

Results

Read a message from Chairman and CEO Ron Kruszewski here.

About Stifel Institutional

Stifel’s mission is to offer expert guidance and resources to help you achieve your goals.

Stifel is a global full-service investment bank offering brokerage, trading, research, underwriting, and advisory services. We build long-term client relationships and deliver tailored solutions across public and private markets through the depth of our platform and expertise.

About Us

Learn how Stifel supports clients across a wide spectrum of strategic situations

Learn More

Capabilities

Artboard-1-copy-63

Investment Banking

Full-service investment banking. Deep industry experience. A leader in the middle market.
Artboard-1-copy-64

Fixed Income Capital Markets

Coverage of over 4,200 accounts in 36 offices nationwide.
Artboard-1-copy-65

Equity Research

Industry-leading provider of timely, actionable research on nearly 1,600 global stocks.
Artboard-1-copy-167

Public Finance

Serving large states and cities, rural school districts, small towns, and everything in between.
Artboard-1-copy-166

Equities

Differentiated, research-driven products with a focus on value and service.
Artboard-1-copy-143

Serving Business Leaders

Investment management and services for institutions and individuals over a variety of asset classes.

Notable Transactions

Image
$ 175,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Mar 2025

Image
$ 202,000,000
Joint Bookrunning Manager

Initial Public Offering

Medtech

Mar 2025

Image
Lender

Senior Secured Credit Facilities

Engineering & Construction, and Infrastructure

Mar 2025

Image
Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Mar 2025

Image
C$ 17,400,000
Sole Bookrunner

Follow-on Offering

Metals & Mining

Feb 2025

Image
C$ 39,005,077
Joint Bookrunner

Private Placement

Metals & Mining

Feb 2025

Image
€ 1,320,000,000
Joint Bookrunner/Joint Lead Financial Advisor

Refinancing

Gaming & Leisure

Feb 2025

Image
A$ 80,000,000
Joint Lead Arranger & Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2025

Image
C$ 131,000,000
Advisor to Seller

Mergers & Acquisitions

Industrial & Environmental Services

Feb 2025

Image
$ 384,000,000
Joint Bookrunner

Initial Public Offering

Building Products

Feb 2025

Image
$ 219,200,000
Joint Bookrunner

Initial Public Offering

Biopharma

Feb 2025

Image
$ 150,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Feb 2025

Image
$ 230,000,000
Left Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2025

Image
Advisor to Buyer

Mergers & Acquisitions

Healthcare

Feb 2025

Image
$ 75,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Jan 2025

Image
Advisor to Seller

Mergers & Acquisitions

Software

Dec 2024

Image
Advisor to Pieris

Mergers & Acquisitions

HealthTech

Dec 2024

Image
$ 50,000,000
Joint Bookrunner

Registered Direct

Biopharma

Dec 2024

Image
$ 257,600,000
Joint Bookrunner

Follow-on Offering

Biopharma

Dec 2024

Image
$ 624,800,000
Joint Bookrunner

Initial Public Offering

Software

Dec 2024

Image
Advisor to Seller

Mergers & Acquisitions

HealthTech

Dec 2024

Image
$ 1,075,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Packaging, Diversified Industries

Dec 2024

Image
$ 350,000,000
Joint Bookrunner

Senior Secured Notes

Paper & Forest Products, Diversified Industries

Dec 2024

Image
Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Dec 2024

Image
$ 402,500,000
Joint Bookrunner

Follow-on Offering

Biopharma

Dec 2024

Image
$ 115,000,000
Joint Bookrunner

Confidentially Marketed Follow-on Offering

Aerospace, Defense & Government Services

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Food & Beverage

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Business Services

Dec 2024

Image
$ 390,000,000
Advisor to Seller

Mergers & Acquisitions

Transportation & Logistics

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Tech-Enabled Services

Nov 2024

Image
$ 196,956,533
Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Nov 2024

Image
Advisor to Seller

Mergers & Acquisitions

Software

Nov 2024

Image
Advisor to Seller

Mergers & Acquisitions

Restaurants

Nov 2024

Image
$ 152,500,000
Joint Bookrunner

Follow-on Offering

Aerospace, Defense & Government Services

Nov 2024

Image
$ 900,000,000
Joint Bookrunner

Senior Secured Notes

Food & Beverage

Nov 2024

Image
$ 610,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Food & Beverage

Nov 2024

Image
Advisor to Buyers

Mergers & Acquisitions

Food & Beverage

Nov 2024

Image
$ 60,000,000
Joint Bookrunner & Joint Placement Agent

Registered Direct & PIPE

Biopharma

Nov 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Biopharma

Oct 2024

Image
$ 2,435,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Tech-Enabled Services

Oct 2024

Image
$ 2,200,000,000
Advisor to Buyer

Mergers & Acquisitions

Tech-Enabled Services

Oct 2024

Image
Sole Financial Advisor

Mergers & Acquisitions

Healthcare Services

Oct 2024

Image
$ 172,499,859
Joint Bookrunner

Follow-on Offering

Aerospace, Defense & Government Services

Oct 2024

Image
Advisor to Seller

Mergers & Acquisitions

Transportation & Logistics

Sep 2024

Image
Advisor to Seller

Mergers & Acquisitions

Software

Sep 2024

Image
$ 94,500,000
Joint Bookrunner

Follow-on Offering

Real Estate

Sep 2024

Image
$ 517,500,000
Joint Bookrunner

Follow-on Offering

Industrial & Environmental Services

Sep 2024

Image
$ 150,000,000
Joint Bookrunner

Senior Notes

Energy & Natural Resources

Sep 2024

Image
$ 575,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Sep 2024

Image
$ 187,680,000
Joint Bookrunner

Initial Public Offering

Biopharma

Sep 2024

Dollar volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.

Awards & Recognitions

National and international recognition of Stifel’s successful approach.

Top Ranked

U.S. Mid-Market Equity House of the Year

International Financing Review, 2023

Leader

In Volume of Senior Managed Negotiated Municipal Bond Issues2

Thomson Reuters

Largest

Provider of Global Small-Cap Equity Research Coverage3

Company data as of 12/31/24

Insights & Perspectives

Stifel_BioPharma_Future-Of_Biotech_Tim-Opler

Interview

Q&A with Tim Opler: The Future of Biotech Is Bright

Healthcare
Stifel-People_Petra-Kormanik

Video

Stifel People with Petra Kormanik

Investment Banking
Potomac Perspective - Washington Policy Strategy

Podcast

Deals & Ideals

Washington Policy
Stifel_BioPharma-Market-Update_Tim-Opler

Report

Biopharma Market Update

Healthcare | Investment Banking
Learn more

Stay up to date with the trends shaping markets, economies, and industries at home and across the world. Here’s Stifel in the press.

Media & Press
CTA_Media

Back to top
About Us Stifel Institutional Stifel Sustainability Practices
Capabilities Investment Banking Equities Equity Research Fixed Income Capital Markets Public Finance Serving Business Leaders
Global Coverage Overview Europe & UK Canada Asia Israel Latin America
Insights & Perspectives Thought Leadership Stifel in the News Stifel Investor Insights Stifel IRIS
Careers Experienced Professionals Campus Careers & Entry Level Opportunities
Disclosures Important Disclosures Your Privacy Form CRS FINRA BrokerCheck
Connect with Stifel Client Access Stifel Wealth Tracker
STF-footer-logo

In the United States, this site is published in the United States for U.S. residents only. The information on this web site is not an offer to sell or a solicitation of an offer to buy any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase, or sale may not lawfully be made. Stifel Financial Advisors may only conduct business with residents of the states in which they are properly registered. References to Stifel herein may apply to parent company Stifel Financial Corp. or any of its wholly owned subsidiaries, including Stifel, Nicolaus & Company, Incorporated, Member NYSE, FINRA, and SIPC. Stifel Nicolaus Europe Limited is authorised and regulated by the Financial Conduct Authority.

Copyright © 2025 Stifel Financial Corp. All rights reserved.